Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

How Should Genetic Counseling for Ovarian Cancer Be Implemented in a Middle-Income Country? An Insight Based on the Brazilian Scenario.

Koike Folgueira MAA, Maistro S, Teixeira N, Mourits MJE, Chammas R, Hendrika de Bock G.

J Glob Oncol. 2018 Sep;4:1-3. doi: 10.1200/JGO.17.00230. No abstract available.

2.

Somatic mutations in early onset luminal breast cancer.

Encinas G, Sabelnykova VY, de Lyra EC, Hirata Katayama ML, Maistro S, de Vasconcellos Valle PWM, de Lima Pereira GF, Rodrigues LM, de Menezes Pacheco Serio PA, de Gouvêa ACRC, Geyer FC, Basso RA, Pasini FS, Del Pilar Esteves Diz M, Brentani MM, Guedes Sampaio Góes JC, Chammas R, Boutros PC, Koike Folgueira MAA.

Oncotarget. 2018 Apr 27;9(32):22460-22479. doi: 10.18632/oncotarget.25123. eCollection 2018 Apr 27.

3.

Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.

Carraro DM, Koike Folgueira MA, Garcia Lisboa BC, Ribeiro Olivieri EH, Vitorino Krepischi AC, de Carvalho AF, de Carvalho Mota LD, Puga RD, do Socorro Maciel M, Michelli RA, de Lyra EC, Grosso SH, Soares FA, Achatz MI, Brentani H, Moreira-Filho CA, Brentani MM.

PLoS One. 2013;8(3):e57581. doi: 10.1371/journal.pone.0057581. Epub 2013 Mar 1.

4.

Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvant chemotherapy.

Koike Folgueira MA, Brentani H, Carraro DM, De Camargo Barros Filho M, Hirata Katayama ML, Santana de Abreu AP, Mantovani Barbosa E, De Oliveira CT, Patrão DF, Mota LD, Netto MM, Caldeira JR, Brentani MM.

Oncol Rep. 2009 Oct;22(4):805-13.

PMID:
19724859
5.

Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow.

Abreu AP, Milani C, Katayama ML, Barbosa KC, Gomes da Fonseca L, Goes JC, Brentani MM, Koike Folgueira MA.

Int J Biol Markers. 2008 Oct-Dec;23(4):219-24.

PMID:
19199269

Supplemental Content

Loading ...
Support Center